Search Results - Jonathan A. Ledermann

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Olaparib as maintenance treatment for patients with platinum-sensitive relapsed ovarian cancer by Jonathan A. Ledermann, Eric Pujade-Lauraine

    Published in Therapeutic Advances in Medical Oncology (2019-05-01)
    Get full text
    Article


  2. 2

    Controversies and clinical unknowns in the use of PARP inhibitors in ovarian cancer by Uma A. Mukherjee, Rowan E. Miller, Jonathan A. Ledermann

    Published in Therapeutic Advances in Medical Oncology (2025-06-01)
    Get full text
    Article


  3. 3

    Self-supervised deep learning for highly efficient spatial immunophenotypingResearch in context by Hanyun Zhang, Khalid AbdulJabbar, Tami Grunewald, Ayse U. Akarca, Yeman Hagos, Faranak Sobhani, Catherine S.Y. Lecat, Dominic Patel, Lydia Lee, Manuel Rodriguez-Justo, Kwee Yong, Jonathan A. Ledermann, John Le Quesne, E. Shelley Hwang, Teresa Marafioti, Yinyin Yuan

    Published in EBioMedicine (2023-09-01)
    Get full text
    Article


  4. 4

    Maintenance treatment with rucaparib for recurrent ovarian carcinoma in ARIEL3, a randomized phase 3 trial: The effects of best response to last platinum‐based regimen and disease... by Ana Oaknin, Amit M. Oza, Domenica Lorusso, Carol Aghajanian, Andrew Dean, Nicoletta Colombo, Johanne I. Weberpals, Andrew R. Clamp, Giovanni Scambia, Alexandra Leary, Robert W. Holloway, Margarita Amenedo Gancedo, Peter C. Fong, Jeffrey C. Goh, David M. O’Malley, Deborah K. Armstrong, Susana Banerjee, Jesus García‐Donas, Elizabeth M. Swisher, Terri Cameron, Lara Maloney, Sandra Goble, Jonathan A. Ledermann, Robert L. Coleman

    Published in Cancer Medicine (2021-10-01)
    Get full text
    Article


Search Tools: